China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally.

Total Assets Chart for China Resources Sanjiu Medical & Pharmaceutical Co Ltd

China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) total assets for FY2025 were CNY 58.8B, a 46.7% change from FY2024. China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total assets grew from CNY 1.5B in 1997 to CNY 58.8B in 2025 (3906.1% over 28 years). Total assets compound annual growth rate: 5-year CAGR of 21.6%, 10-year CAGR of 17.2%, 20-year CAGR of 11.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥41.24B
Implied Share Price
¥24.78
Enterprise Value
¥43.22B
Revenue (TTM)
¥31.03B
EBITDA
¥5.70B
Profit Margin
10.40%
Trailing P/E
12.58
Forward P/E
16.47
Price/Book (MRQ)
2.19
Price/Sales (TTM)
1.33
EV/EBITDA
8.41
EV/Revenue
1.53
Dividend Yield
2.36%
Book Value
¥13.82
Free Cash Flow (FY2025)
¥4.24B
Free Cash Flow Yield
10.29%

Snapshot as of 25th October 2026 — not point-in-time controlled, may lag the live market by a few days.